Comprise the lasting coating that discharges or the compositions of substrate and nmda receptor antagonist, and method from this nmda receptor antagonist to the curee that use
CN101060830A
Combination of a NMDA receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
CN1929830A
Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNA disorders, and method therefor
AU2005215775A1
Combination of a NMDA receptor antagonist and an anti-depressive drug MAO-inhibitor or a GADPH-inhibitor for the treatment of psychiatric conditions
CA2554959A1
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
EP1638931A2
Method of targeting a therapeutic agent
AU2004226334A1
Treatment of demyelinating conditions
CA2520243A1
Pharmaceutical compositions for treating painful neuropathy and methods of treating same
US2003135042A1
Atypical antipsychotic agents having low affinity for the D2 Receptor
EP1852113A2
Methods for treating neuropsychiatric disorders with NMDA receptors antagonists
MXPA03005130A
Methods for treating neuropsychiatric disorders with nmda receptor antagonists.
